Anika Koop
Medizinische Hochschule Hannover(DE)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, Immunotherapy and Immune Responses
Most-Cited Works
- → Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity(2017)218 cited
- → Reinduction of PD1-inhibitor therapy: first experience in eight patients with metastatic melanoma(2017)54 cited
- → Intermittent BRAF-inhibitor therapy is a feasible option: report of a patient with metastatic melanoma(2013)21 cited